Variant report

Variant	nsv884064
Chromosome Location	chr6:30375290-30396173
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:283)
CpG islands
(count:0)
Chromatin interactive
region (count:10)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:283 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr6:30379289-30379550	H1-hESC	embryonic stem cell:	n/a	n/a
2	BATF	chr6:30379269-30379413	GM12878	blood:	n/a	n/a
3	BHLHE40	chr6:30379306-30379933	K562	blood:	n/a	n/a
4	BHLHE40	chr6:30379732-30379883	HepG2	liver:	n/a	n/a
5	CBX3	chr6:30376909-30377342	K562	blood:	n/a	n/a
6	CBX3	chr6:30379195-30379551	K562	blood:	n/a	n/a
7	CBX3	chr6:30376983-30377377	HCT-116	colon:	n/a	n/a
8	CBX3	chr6:30376972-30377321	K562	blood:	n/a	n/a
9	CEBPB	chr6:30377261-30377439	K562	blood:	n/a	n/a
10	CEBPB	chr6:30387972-30388090	K562	blood:	n/a	n/a
11	CTCF	chr6:30379234-30379563	GM19238	blood:	n/a	n/a
12	CTCF	chr6:30379340-30379490	Caco-2	colon:	n/a	n/a
13	CTCF	chr6:30379267-30379449	A549	lung:	n/a	n/a
14	CTCF	chr6:30379340-30379490	K562	blood:	n/a	n/a
15	CTCF	chr6:30379380-30379530	HCT-116	colon:	n/a	n/a
16	CTCF	chr6:30379232-30379610	H1-hESC	embryonic stem cell:	n/a	n/a
17	CTCF	chr6:30379244-30379549	Hela-S3	cervix:	n/a	n/a
18	CTCF	chr6:30379246-30379555	H1-hESC	embryonic stem cell:	n/a	n/a
19	CTCF	chr6:30378940-30379090	AG04449	skin:	n/a	n/a
20	CTCF	chr6:30379340-30379490	GM06990	blood:	n/a	n/a
21	CTCF	chr6:30379243-30379557	MCF-7	breast:	n/a	n/a
22	CTCF	chr6:30379340-30379490	HMF	breast:	n/a	n/a
23	CTCF	chr6:30379300-30379450	GM12872	blood:	n/a	n/a
24	CTCF	chr6:30379340-30379490	HPAF	blood vessel:	n/a	n/a
25	CTCF	chr6:30379340-30379490	BJ	skin:	n/a	n/a
26	CTCF	chr6:30379225-30379583	Gliobla	brain:	n/a	n/a
27	CTCF	chr6:30379320-30379470	NB4	blood:	n/a	n/a
28	CTCF	chr6:30379340-30379490	Hela-S3	cervix:	n/a	n/a
29	CTCF	chr6:30379340-30379490	AoAF	blood vessel:	n/a	n/a
30	CTCF	chr6:30379320-30379470	HCM	heart:	n/a	n/a
31	CTCF	chr6:30379245-30379524	HUVEC	blood vessel:	n/a	n/a
32	CTCF	chr6:30379206-30379437	A549	lung:	n/a	n/a
33	CTCF	chr6:30378980-30379130	HEK293	kidney:	n/a	n/a
34	CTCF	chr6:30382061-30382114	MCF-7	breast:	n/a	n/a
35	CTCF	chr6:30379340-30379490	HA-sp	spinal cord:	n/a	n/a
36	CTCF	chr6:30379248-30379527	MCF-7	breast:	n/a	n/a
37	CTCF	chr6:30379340-30379490	GM12873	blood:	n/a	n/a
38	CTCF	chr6:30379120-30379270	HAc	cerebellar:	n/a	n/a
39	CTCF	chr6:30379246-30379507	GM20000	blood:	n/a	n/a
40	CTCF	chr6:30379900-30380050	AG09319	gingival:	n/a	n/a
41	CTCF	chr6:30379340-30379490	HCPEpiC	choroid plexus:	n/a	n/a
42	CTCF	chr6:30379340-30379490	HMEC	breast:	n/a	n/a
43	CTCF	chr6:30379237-30379545	K562	blood:	n/a	n/a
44	CTCF	chr6:30379320-30379470	HEEpiC	esophagus:	n/a	n/a
45	CTCF	chr6:30379243-30379514	LNCaP	prostate:	n/a	n/a
46	CTCF	chr6:30379250-30379528	GM12878	blood:	n/a	n/a
47	CTCF	chr6:30378900-30379050	HA-sp	spinal cord:	n/a	n/a
48	CTCF	chr6:30396171-30396268	GM20000	blood:	n/a	n/a
49	CTCF	chr6:30379380-30379530	HAc	cerebellar:	n/a	n/a
50	CTCF	chr6:30379300-30379450	GM12870	blood:	n/a	n/a

No data

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:30383321..30385236-chr6:30386462..30388698,2	MCF-7	breast:
2	chr6:30384989..30387983-chr6:30390745..30393003,2	K562	blood:
3	chr6:30364310..30365862-chr6:30386384..30388997,2	MCF-7	breast:
4	chr6:30383321..30385236-chr6:30386462..30388698,2	MCF-7	breast:
5	chr6:30386050..30388643-chr6:30391720..30393576,2	MCF-7	breast:
6	chr6:30380952..30384667-chr6:30386673..30389385,3	K562	blood:
7	chr6:30378981..30379484-chr6:30421470..30421976,2	K562	blood:
8	chr6:30384989..30387983-chr6:30390745..30393003,2	K562	blood:
9	chr6:30383090..30385437-chr6:30435518..30438208,2	K562	blood:
10	chr6:30386050..30388643-chr6:30391720..30393576,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GNL1-2	chr6:30390025-30390238	l_3159_chr6:30370222-30402164_hela

No data

Variant related genes	Relation type
MICC	TF binding region
ENSG00000224936	chromatin interactions
ENSG00000226577	chromatin interactions

Extended variants
information (count: 360 )
Associated
traits (count: 110 )

Variant overlapped rSNPs/rCNVs (count:360 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs189776690	chr6:30377494-30377495	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs536879447	chr6:30378519-30378520	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs200956542	chr6:30378543-30378544	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs552336350	chr6:30378544-30378545	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs143752830	chr6:30378548-30378549	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs557922478	chr6:30378580-30378581	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs9261817	chr6:30378601-30378602	Inactive region	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
8	rs573293352	chr6:30378612-30378613	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs577717016	chr6:30378890-30378891	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs141504761	chr6:30378969-30378970	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs9261819	chr6:30378989-30378990	Inactive region	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs549286810	chr6:30378994-30378995	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs186465780	chr6:30379036-30379037	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs9261820	chr6:30379037-30379038	Inactive region	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs541365586	chr6:30379051-30379052	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs9261821	chr6:30379074-30379075	Inactive region	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
17	rs192109302	chr6:30379108-30379109	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs9261822	chr6:30379200-30379201	Inactive region	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs375381259	chr6:30379217-30379218	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs368240191	chr6:30379221-30379222	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs535755654	chr6:30379231-30379232	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs372355811	chr6:30379235-30379236	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs542040609	chr6:30379252-30379253	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs576865468	chr6:30379279-30379280	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs555988900	chr6:30379280-30379281	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs150884471	chr6:30379328-30379329	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs534840264	chr6:30379342-30379343	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs541084117	chr6:30379351-30379352	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs369305581	chr6:30379353-30379354	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs559479174	chr6:30379354-30379355	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs543556577	chr6:30379397-30379398	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs563319838	chr6:30379415-30379416	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs529760216	chr6:30379434-30379435	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs377357020	chr6:30379436-30379437	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs9261823	chr6:30379443-30379444	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs188631075	chr6:30379444-30379445	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs559570011	chr6:30379476-30379477	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs528379222	chr6:30379482-30379483	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs369145211	chr6:30379506-30379507	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs551562736	chr6:30379510-30379511	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs563470646	chr6:30379524-30379525	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs567262600	chr6:30379564-30379565	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs9261825	chr6:30379596-30379597	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs546279120	chr6:30379609-30379610	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs9261826	chr6:30379611-30379612	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs535024108	chr6:30379632-30379633	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs538766240	chr6:30379660-30379661	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs374094114	chr6:30379664-30379665	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs557926126	chr6:30379698-30379699	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs571535072	chr6:30379735-30379736	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:110)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571809	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
abnormal development	18461090	CNVD
Melanoma	17363583	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Breast cancer	21364760	CNVD
Lung cancer	21569311	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:51 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:30379400-30379600	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
2	chr6:30379400-30379600	Bivalent Enhancer	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
3	chr6:30379400-30379600	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr6:30379400-30379600	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
5	chr6:30379400-30379600	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
6	chr6:30379400-30379600	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
7	chr6:30379400-30379600	Flanking Bivalent TSS/Enh	Primary T cells effector/memory enriched fromperipheralblood	blood
8	chr6:30379400-30379600	Flanking Bivalent TSS/Enh	Primary T killer naive cells fromperipheralblood	blood
9	chr6:30379400-30379600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr6:30379400-30379600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
11	chr6:30379400-30379600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
12	chr6:30379400-30379600	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
13	chr6:30379400-30379600	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
14	chr6:30379400-30379600	Flanking Active TSS	Brain Anterior Caudate	brain
15	chr6:30379400-30379600	Flanking Active TSS	Brain Substantia Nigra	brain
16	chr6:30379400-30379600	Bivalent Enhancer	Fetal Thymus	thymus
17	chr6:30379400-30379600	Enhancers	Gastric	stomach
18	chr6:30379400-30379600	Flanking Bivalent TSS/Enh	Left Ventricle	heart
19	chr6:30379400-30379600	Bivalent Enhancer	Right Atrium	heart
20	chr6:30379400-30379600	Flanking Active TSS	Spleen	Spleen
21	chr6:30379400-30379600	Enhancers	HepG2	liver
22	chr6:30379400-30379600	Enhancers	K562	blood
23	chr6:30379400-30379800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
24	chr6:30379400-30379800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
25	chr6:30379400-30379800	Bivalent Enhancer	Primary B cells from peripheral blood	blood
26	chr6:30379400-30379800	Bivalent Enhancer	Primary T cells from cord blood	blood
27	chr6:30379400-30379800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
28	chr6:30379400-30379800	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
29	chr6:30379400-30379800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
30	chr6:30379400-30379800	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
31	chr6:30379400-30379800	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
32	chr6:30379400-30379800	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
33	chr6:30379400-30379800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
34	chr6:30379400-30379800	Bivalent Enhancer	Psoas Muscle	Psoas
35	chr6:30379400-30380000	Enhancers	Pancreas	Pancrea
36	chr6:30379600-30379800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
37	chr6:30379600-30379800	Bivalent/Poised TSS	Primary T helper memory cells from peripheral blood 2	blood
38	chr6:30379600-30379800	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
39	chr6:30379600-30379800	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
40	chr6:30379600-30379800	Flanking Active TSS	HepG2	liver
41	chr6:30379600-30380000	Active TSS	Spleen	Spleen
42	chr6:30382400-30382600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
43	chr6:30384000-30384200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
44	chr6:30384600-30384800	Bivalent/Poised TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
45	chr6:30384600-30384800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
46	chr6:30384800-30386000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr6:30386000-30386200	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
48	chr6:30386000-30386600	Bivalent/Poised TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
49	chr6:30386800-30387000	Bivalent Enhancer	Brain Germinal Matrix	brain
50	chr6:30387000-30387200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links